文献速递心境障碍

卤代DMT类似物的神经药理学:5-Br-DMT的促神经可塑性与抗抑郁特性

Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential.
PubMed 文献 · Mol Psychiatry · 2025-10-21

本研究表征了5-F-DMT、5-Cl-DMT和5-Br-DMT三种卤代DMT衍生物的药理活性、行为效应和治疗潜力。研究发现5-Br-DMT激活5-HT2AR但不诱导小鼠甩头反应,上调前额叶皮层和海马中与神经可塑性相关的即早基因并促进皮层神经元树突生长;在小鼠应激性抑郁模型中,单次给药(10 mg/kg,腹腔注射)显著减少抑郁样行为,提示快速抗抑郁效应。

要点

  • 5-Br-DMT激活5-HT2AR但不诱导小鼠甩头反应,提示非致幻活性。
  • 5-Br-DMT上调小鼠前额叶皮层和海马中Arc、Egr-1、-2、-3等即早基因。
  • 小鼠应激性抑郁模型中单次腹腔注射10 mg/kg 5-Br-DMT显著减少抑郁样行为。

核心结论

  • 5-Br-DMT是一种具有抗抑郁特性的非致幻促神经可塑性剂,支持其作为原型候选物进一步研究。

研究设计与样本

  • 研究采用体外实验、计算机模拟和体内行为与基因表达研究相结合的方法,表征5-F-DMT、5-Cl-DMT和5-Br-DMT的药理活性、行为效应和治疗潜力。

主要发现

  • 5位卤素取代调节了对关键5-HT受体(5-HT1A/2A/2B/2CR)和转运体(SERT)的亲和力与选择性。
  • 5-Br-DMT激活5-HT2AR但不诱导小鼠甩头反应,提示非致幻活性。
  • 5-Br-DMT上调小鼠前额叶皮层和海马中与神经可塑性相关的即早基因(Arc、Egr-1、-2、-3)并促进皮层神经元树突生长。
  • 在小鼠应激性抑郁模型中,单次腹腔注射10 mg/kg 5-Br-DMT显著减少抑郁样行为,反映快速抗抑郁效应。

关键数值与推荐

  • 5-Br-DMT在应激性抑郁小鼠模型中的单次给药剂量为10 mg/kg,腹腔注射。

临床怎么用

  • 5-Br-DMT作为非致幻促神经可塑性剂,其快速抗抑郁效应提示可能为 mood disorders 提供新型治疗候选。
  • 卤代DMT衍生物的构效关系信息可能指导未来治疗化合物的设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current first-line antidepressants, such as selective serotonin reuptake inhibitors (SSRI), often present a delayed onset of action and fail to effectively treat a large proportion of patients, leaving a gap in the treatment of mood disorders. Psychedelics have recently emerged as promising alternatives due to their ability to produce fast-acting antidepressant effects through neuroplastic adaptations, but their hallucinogenic properties remain a major obstacle to their widespread therapeutic use. In this study, we characterized a novel class of halogenated DMT derivatives-5-F-DMT, 5-Cl-DMT, and 5-Br-DMT-for their pharmacological activity, behavioral effects, and therapeutic potential. Using a combination of in vitro assays, in silico modeling, and in vivo behavioral and gene expression studies, we found that halogen substitution at the 5-position modulates receptor affinity and selectivity across key serotonin (5-HT) receptors (5-HT1A/2 A/2B/2CR) and transporter (SERT). Notably, 5-Br-DMT was found to activate 5-HT2AR but did not induce the head twitch response (HTR) in mice, suggesting non-hallucinogenic activity. Furthermore, 5-Br-DMT upregulated immediate early genes (IEGs) associated with neuroplasticity in the mouse prefrontal cortex and hippocampus (Arc, Egr-1, -2 and -3) and promoted dendritic growth in cortical neurons. In a mouse model of stress-induced depression, a single administration (10 mg/kg, i.p.) of 5-Br-DMT resulted in a significant reduction in depressive-like behavior, reflecting rapid antidepressant effects. Collectively, our results highlight 5-Br-DMT as a non-hallucinogenic psychoplastogen with antidepressant properties, supporting its potential as a prototypical candidate for further study. Moreover, the evaluation and biological characterization of the halogenated DMT derivatives offers valuable information on structure-activity relationships that may guide the design of future therapeutic compounds.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Puigseslloses P, Nadal-Gratacós N, Fumàs B, et al. Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential. Mol Psychiatry. 2025. PMID: 41120735. doi:10.1038/s41380-025-03308-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。